Thermo Fisher Scientific Inc - Payout Ratio History
Payout ratio history for stock TMO (Thermo Fisher Scientific Inc).
| Date | Payout ratio |
|---|---|
| April 2024 | 10.21% |
| March 2024 | 10.21% |
| February 2024 | 9.16% |
| January 2024 | 6.35% |
| December 2023 | 6.35% |
| November 2023 | 5.79% |
| October 2023 | 5.69% |
| September 2023 | 5.68% |
| August 2023 | 5.29% |
| July 2023 | 5.29% |
| June 2023 | 5.27% |
| May 2023 | 5.24% |
| April 2023 | 5.23% |
| March 2023 | 4.49% |
| February 2023 | 5.16% |
| January 2023 | 5.16% |
| December 2022 | 6.10% |
| November 2022 | 4.97% |
| October 2022 | 4.91% |
| September 2022 | 6.10% |
| August 2022 | 5.52% |
| July 2022 | 5.52% |
| June 2022 | 5.52% |
| May 2022 | 5.52% |
| April 2022 | 5.52% |
| March 2022 | 4.79% |
| February 2022 | 4.79% |
| January 2022 | 5.27% |
| December 2021 | 5.27% |
| October 2021 | 4.81% |
| September 2021 | 4.81% |
| August 2021 | 5.23% |
| July 2021 | 5.23% |
| June 2021 | 5.23% |
| May 2021 | 6.51% |
| April 2021 | 6.51% |
| March 2021 | 5.51% |
| February 2021 | 7.21% |
| January 2021 | 7.21% |
| December 2020 | 6.22% |
| November 2020 | 6.18% |
| October 2020 | 8.16% |
| September 2020 | 8.16% |
| August 2020 | 8.16% |
| July 2020 | 8.27% |
| June 2020 | 8.27% |
| May 2020 | 10.50% |
| April 2020 | 10.50% |
| March 2020 | 10.50% |
| February 2020 | 10.50% |
| January 2020 | 10.50% |
| December 2019 | 10.50% |
| November 2019 | 10.50% |
| October 2019 | 10.50% |
| September 2019 | 10.50% |
| August 2019 | 10.50% |
| July 2019 | 10.50% |
| June 2019 | 10.50% |
| May 2019 | 10.50% |
| April 2019 | 10.50% |
| March 2019 | 10.50% |
| February 2019 | 9.38% |
| December 2018 | 10.40% |
| December 2017 | 10.20% |
| December 2016 | 12% |
| December 2015 | 12.20% |
| December 2014 | 14.50% |
| December 2013 | 16.50% |
| December 2012 | 15.70% |
| December 2011 | 12.43% |
TMO
List: Challengers
Price: $576.74
Dividend Yield: 0.00%
Forward Dividend Yield: 0.27%
Payout Ratio: 10.21%
Dividend Per Share: 1.56 USD
Earnings Per Share: 15.43 USD
P/E Ratio: 35.82
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1.2 million
Ebitda: 1.6 billionMarket Capitalization: 215.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 13
DGR3: 16.53%
DGR5: 15.07%
DGR10: 8.58%